Form 8-K - Current report:
SEC Accession No. 0001628280-24-028764
Filing Date
2024-06-18
Accepted
2024-06-18 16:07:53
Documents
15
Period of Report
2024-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zlab-20240618.htm   iXBRL 8-K 117241
2 EX-10.1 exhibit1012024equityincent.htm EX-10.1 140509
  Complete submission text file 0001628280-24-028764.txt   457512

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20240618.xsd EX-101.SCH 2270
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zlab-20240618_def.xml EX-101.DEF 15888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zlab-20240618_lab.xml EX-101.LAB 27758
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zlab-20240618_pre.xml EX-101.PRE 16626
18 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20240618_htm.xml XML 4062
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 241051757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)